This specialty practice discussion group is intended for discussion of inpatient staff hospital issues.... View more
This specialty practice discussion group is intended for discussion of inpatient staff hospital issues. Remember that anything published in this community can be seen by any member of the community. Please be considerate of the HIPAA Privacy Rule when posting to the community.
Are you sure you want to leave ?
Reply To: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios
We staff dinutuximab patients 2:1 (2 patients : 1 nurse) while the chimeric is infusing. We staff 3:1 in between doses if patient is stable.
For Blin, we staff 2:1 for initial infusion and until patient is deemed stable
Both are driven by frequency of vital signs, dose changes, patient stability and pain control
—————————— Julie Juno-LaPan, MS,RN-BC, CNML Clinical Nursing Director 7 East Pediatric PHO/BMT CS Mott Children’s Hospital Ann Arbor, MIchigan USA (734)763-4515 —————————— ——————————————- Original Message: Sent: 08-30-2022 11:38 AM From: Erin Jones Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios
I’m in the very same boat right now defending all of our staffing ratios, but especially anything 2:1. I have not been able to find much at all in regards to staffing ratios for pediatric oncology patients, much less staffing ratios for specific therapies, in a literature review. The comments I’ve found here have been my best resource so far, but if you find others, please share!
We put Dinatuxumab patients in a 2:1 assignment, though staffing constraints continue to make that very challenging. They are usually on a ketamine drip with our pain team managing that component. Our blinatumomab patients we staff in a 3:1 ratio. I hope you get a robust number of responses to this thread because benchmarking would be helpful!
—————————— Erin Jones, MHA, BSN, RN, CCRN-K | Patient Services Manager III 5 Children’s | Pediatric Hematology, Oncology, Bone Marrow Transplant, and Cardiology NC Children’s Hospital UNC Health Chapel Hill, NC ——————————
Original Message: Sent: 08-30-2022 07:34 AM From: Alyssa Henderson Subject: Blinatumomab, Dinutuximab, and Other Biotherapy Nurse Staffing Ratios
Hello everyone! I am the assistant nurse manager at Hackensack UMC in Hackensack, NJ and I am looking for documentation to support my inpatient unit’s 1:2 nurse:patient staffing ratio for blinatumomab, dinutuximab, and other biotherapy infusions. I am in the process of conducting a literature search but not having much luck. Would you mind sharing your hospital name and pediatric biotherapy infusion staffing ratios (specifically blina & dinutux if possible)? Also, if anyone has literature to support lower staffing ratios for these infusions I would sincerely appreciate it! Thank you in advance!!